HUADONG MEDICINE
00096325.911.18% ( -0.31 )
Financials
Q3 2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: HUADONG MEDICINE(000963) the Revenue is 10.95 B (-0.33%), Miss estimate;the EBIT is 1.085 B (-2.02%), Miss estimate;the EPS is 0.52 (-3.78%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
10.95B0.33%
11.29B2.78%
-0.34B3.11%
EBITMiss expectations
1.08B2.02%
1.09B1.71%
-0.00B0.31%
EPSExceed expectations
0.51963.78%
0.51354.91%
+0.00611.13%
Upcoming earnings report - FY2026 Annual Earning Release
Available dateApr 23, 2027
Estimate Revenue44.15 B
Estimate EBIT4.254 B
Estimate EPS1.9729
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly